Related Experiment Video
Updated: Jan 18, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Synergistic Therapeutic Potential of Curcumin and Metformin: a Multipathway Approach to Disease Management
Hadiseh Mohammadi1, Sahar Ghoflchi1, Kasim Sakran Abass2
1Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
Metformin, a first-line pharmacologic agent for type 2 diabetes, exerts its primary antidiabetic effects by suppressing hepatic gluconeogenesis via both AMP-activated protein kinases-dependent and -independent pathways. Beyond glycemic control, metformin exhibits pleiotropic benefits, including improved insulin sensitivity, modulation of gut microbiota, and protection against various metabolic, cardiovascular, renal, neurodegenerative, and inflammatory diseases. However, its clinical use is often limited by gastrointestinal side effects, vitamin B12 deficiency, and rare but serious complications such as lactic acidosis, highlighting the need for adjunctive strategies to enhance efficacy and reduce adverse effects. Curcumin, as a bioactive polyphenol, has garnered significant attention because of its extensive pharmacological activities and excellent safety profile. Curcumin modulates key intracellular signaling pathways, including nuclear factor-kappa B, mitogen-activated protein kinases, and phosphatidylinositol 3-kinase/protein kinase B, providing anti-inflammatory, antioxidant, anticancer, and metabolic regulatory effects. Nonetheless, its clinical application is constrained by poor bioavailability because of limited absorption, rapid metabolism, and systemic elimination. Recent evidence suggests that coadministration of metformin and curcumin yields synergistic therapeutic outcomes in diverse disease models. This combination improves glycemic control, mitigates oxidative stress and inflammation, and provides organ-protective effects, particularly in the liver, heart, and skin. Furthermore, it shows promise in cancer prevention and therapy, polycystic ovary syndrome management, and pain modulation, with enhanced outcomes when delivered via nanoparticle-based systems. This review aims to provide a comprehensive analysis of the combined therapeutic potential of metformin and curcumin across a spectrum of pathological conditions.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacokinetics: Drug–Drug Interactions
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

